These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18815927)

  • 1. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.
    Malats N
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of DNA repair genes in bladder cancer.
    Kiltie AE
    Methods Mol Biol; 2009; 472():281-306. PubMed ID: 19107438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary bladder cancer.
    Kiemeney LA
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):110-5. PubMed ID: 18815925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.
    Horikawa Y; Gu J; Wu X
    Curr Opin Urol; 2008 Sep; 18(5):493-8. PubMed ID: 18670273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and genetic susceptibility to bladder cancer.
    Wu X; Ros MM; Gu J; Kiemeney L
    BJU Int; 2008 Nov; 102(9 Pt B):1207-15. PubMed ID: 19035883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications.
    Wu X; Hildebrandt MA; Chang DW
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):269-80. PubMed ID: 20016998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
    Chang CH; Wang RF; Tsai RY; Wu HC; Wang CH; Tsai CW; Chang CL; Tsou YA; Liu CS; Bau DT
    Anticancer Res; 2009 Oct; 29(10):3903-7. PubMed ID: 19846926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Fontana L; Bosviel R; Delort L; Guy L; Chalabi N; Kwiatkowski F; Satih S; Rabiau N; Boiteux JP; Chamoux A; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(3B):1853-6. PubMed ID: 18630471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular and genetic epidemiology].
    Kang DH
    Exp Mol Med; 2001 Apr; 33(1 Suppl):73-82. PubMed ID: 11708327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.
    Grotenhuis AJ; Vermeulen SH; Kiemeney LA
    Future Oncol; 2010 Sep; 6(9):1433-60. PubMed ID: 20919828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.
    Vineis P; Manuguerra M; Kavvoura FK; Guarrera S; Allione A; Rosa F; Di Gregorio A; Polidoro S; Saletta F; Ioannidis JP; Matullo G
    J Natl Cancer Inst; 2009 Jan; 101(1):24-36. PubMed ID: 19116388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
    Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
    Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder cancer subtypes defined by genomic alterations.
    Knowles MA
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):116-30. PubMed ID: 18815926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
    Knowles MA
    Carcinogenesis; 2006 Mar; 27(3):361-73. PubMed ID: 16352616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Urology; 2009 Mar; 73(3):675-80. PubMed ID: 19041121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
    Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.